Aurinia Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aurinia Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Aurinia Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.18M, a 9.33% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.18M -$430K -9.33% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.29M -$426K -9.04% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.39M -$419K -8.71% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $4.5M -$409K -8.34% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $4.61M -$336K -6.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $4.71M -$365K -7.19% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $4.81M -$419K -8.01% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.91M -$476K -8.84% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $4.95M -$587K -10.6% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.08M -$536K -9.55% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.23M -$529K -9.18% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $5.38M -$106K -1.93% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $5.53M Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $5.62M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $5.76M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5.49M +$5.49M Dec 31, 2020 10-K 2022-02-28
Q4 2019 $0 Dec 31, 2019 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.